BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24639555)

  • 1. Transcription and processing: multilayer controls of RNA biogenesis by the Hippo pathway.
    Yu FX; Guan KL
    EMBO J; 2014 May; 33(9):942-4. PubMed ID: 24639555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion.
    Nouri K; Azad T; Lightbody E; Khanal P; Nicol CJ; Yang X
    FASEB J; 2019 Nov; 33(11):12487-12499. PubMed ID: 31431076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Hippo pathway effectors TAZ/YAP regulate dicer expression and microRNA biogenesis through Let-7.
    Chaulk SG; Lattanzi VJ; Hiemer SE; Fahlman RP; Varelas X
    J Biol Chem; 2014 Jan; 289(4):1886-91. PubMed ID: 24324261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.
    Zhao B; Wei X; Li W; Udan RS; Yang Q; Kim J; Xie J; Ikenoue T; Yu J; Li L; Zheng P; Ye K; Chinnaiyan A; Halder G; Lai ZC; Guan KL
    Genes Dev; 2007 Nov; 21(21):2747-61. PubMed ID: 17974916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of the mammalian Hippo signaling pathway.
    Ji XY; Zhong G; Zhao B
    Yi Chuan; 2017 Jul; 39(7):546-567. PubMed ID: 28757470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer.
    Mori M; Triboulet R; Mohseni M; Schlegelmilch K; Shrestha K; Camargo FD; Gregory RI
    Cell; 2014 Feb; 156(5):893-906. PubMed ID: 24581491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of the Hippo pathway in mouse mammary stem cells promotes mammary tumorigenesis.
    Li H; Gumbiner BM
    Mamm Genome; 2016 Dec; 27(11-12):556-564. PubMed ID: 27601049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
    Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
    J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Snapshots of a hybrid transcription factor in the Hippo pathway.
    Luo X
    Protein Cell; 2010 Sep; 1(9):811-9. PubMed ID: 21203923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A feed forward loop enforces YAP/TAZ signaling during tumorigenesis.
    Gill MK; Christova T; Zhang YY; Gregorieff A; Zhang L; Narimatsu M; Song S; Xiong S; Couzens AL; Tong J; Krieger JR; Moran MF; Zlotta AR; van der Kwast TH; Gingras AC; Sicheri F; Wrana JL; Attisano L
    Nat Commun; 2018 Aug; 9(1):3510. PubMed ID: 30158528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat stress activates YAP/TAZ to induce the heat shock transcriptome.
    Luo M; Meng Z; Moroishi T; Lin KC; Shen G; Mo F; Shao B; Wei X; Zhang P; Wei Y; Guan KL
    Nat Cell Biol; 2020 Dec; 22(12):1447-1459. PubMed ID: 33199845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian NDR/LATS protein kinases in hippo tumor suppressor signaling.
    Hergovich A; Hemmings BA
    Biofactors; 2009; 35(4):338-45. PubMed ID: 19484742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.
    Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A
    Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.
    Tan G; Cao X; Dai Q; Zhang B; Huang J; Xiong S; Zhang Yy; Chen W; Yang J; Li H
    Oncotarget; 2015 Apr; 6(11):8676-86. PubMed ID: 25895125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposing transcriptional and post-transcriptional roles for Scalloped in binary Hippo-dependent neural fate decisions.
    Xie B; Morton DB; Cook TA
    Dev Biol; 2019 Nov; 455(1):51-59. PubMed ID: 31265830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Real-Time PCR to Measure YAP/TAZ Activity in Human Cells.
    Cao X; Zhao B
    Methods Mol Biol; 2019; 1893():137-152. PubMed ID: 30565132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arhgef7 promotes activation of the Hippo pathway core kinase Lats.
    Heidary Arash E; Song KM; Song S; Shiban A; Attisano L
    EMBO J; 2014 Dec; 33(24):2997-3011. PubMed ID: 25425573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway.
    Lei QY; Zhang H; Zhao B; Zha ZY; Bai F; Pei XH; Zhao S; Xiong Y; Guan KL
    Mol Cell Biol; 2008 Apr; 28(7):2426-36. PubMed ID: 18227151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.
    Meng Z; Moroishi T; Mottier-Pavie V; Plouffe SW; Hansen CG; Hong AW; Park HW; Mo JS; Lu W; Lu S; Flores F; Yu FX; Halder G; Guan KL
    Nat Commun; 2015 Oct; 6():8357. PubMed ID: 26437443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifaceted regulation and functions of YAP/TAZ in tumors (Review).
    Liu H; Du S; Lei T; Wang H; He X; Tong R; Wang Y
    Oncol Rep; 2018 Jul; 40(1):16-28. PubMed ID: 29749524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.